-+ 0.00%
-+ 0.00%
-+ 0.00%
The Tokyo Stock Exchange saw Sumitomo Pharma temporarily rise by 6%. This was due to a leukemia drug candidate being designated for the accelerated review system in the US.
Share

Please log in to view news

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending